[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.204.173.45. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editorial
March 19, 2019

The Evidence Supporting Cardiovascular Guidelines: Is There Evidence of Progress in the Last Decade?

Author Affiliations
  • 1Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois
  • 2Editor, JAMA Cardiology
  • 3TIMI Study Group, Brigham and Women’s Hospital, Boston, Massachusetts
JAMA. 2019;321(11):1053-1054. doi:10.1001/jama.2019.2018

For more than 3 decades, the American College of Cardiology/American Heart Association (ACC/AHA) Task Force on Practice Guidelines has contributed substantially to the quality of cardiac care by developing guidelines pertaining to virtually all areas of cardiovascular disease. The intent is to provide health care professionals inundated by an ever-expanding medical literature with the evidence required for optimal patient care. ACC/AHA guidelines are revised and updated periodically, often in collaboration with other professional societies, to keep the documents current and relevant as new knowledge emerges. The purpose of guidelines is to inform clinical practice through a series of recommendations that codify the body of evidence on the disease in question according to the strength (class) of the recommendation and its underpinning level of evidence (LOE).

×